The phenomenon of glycated hemoglobin in patients with a new coronavirus infection (COVID-19) with type 2 diabetes mellitus

Abstract

During the pandemic of coronavirus infection, medical staff around the world has faced the problem of a significant deterioration in the health conditions of patients, who have a history of type 2 diabetes mellitus and who have infected with COVID-19. The problem of the combination of the coronavirus infection and diabetes mellitus is urgent and requires an in-depth study in this context. This article presents and reviews some results of an experiment during which the clinical indicators of 15 patients with type 2 diabetes mellitus, with elevated glycated hemoglobin, infected with coronavirus infection, aged 45 to 65, were taken on the 14th day of observation.

Imprint

Bogdan А. Sklyarov, Alena D. Samoilova, Bogdan V. Pavlov, Anastasia V. Levina, Irina S. Sinelnikova, Susanna М. Vardanyan, Viktor А. Papin The phenomenon of glycated hemoglobin in patients with a new coronavirus infection (COVID-19) with type 2 diabetes mellitus. Cardiometry; No.26 February 2023; p.139-143; DOI: 10.18137/cardiometry.2023.26.139143; Available from: https://www.cardiometry.net/issues/no26-february-2023/the-phenomenon-of-glycated-hemoglobin-in-patients-with-a-new-coronavirus-infection-covid-19